SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors
3 references·16 citing·21 second hop
A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating risks of tr…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Prevention of transfusion-transmitted infections (2019)Prevention of transfusion-tra…The N ational H eart, L ung, and B lood I nstitute R ecipient E pidemiology and D onor E valuation S tudy ( REDS ‐ III ): a research program striving to improve blood donor and transfusion recipient outcomes (2013)The N ational H eart, L ung, …Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Donor Testing and Risk: Curre…Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Transfusion‐associated infect…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation…Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Impact of nucleic acid testin…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…Transfusion-transmitted infections (2007)Transfusion-transmitted infec…Current Risks of Transfusion-Transmitted Agents: A Review (2007)Current Risks of Transfusion-…Current risk for transfusion transmitted infections (2007)Current risk for transfusion …Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Current incidence and estimat…Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Assessing the impact of HBV N…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients (1984)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Standards for blood banks and transfusion services. (1977)Transfusion-transmissible infections among blood donors in Kathmandu, Nepal (2009)Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh (2010)Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India (2015)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case–control study using audio computer‐assisted structured interviews (2013)The Use of Rapid Diagnostic Tests for Transfusion Infectious Screening in Africa: A Literature Review (2014)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern (2020)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited

Cited by

  • 2019Prevention of transfusion-transmitted infections295 cited
  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 2007Transfusion-transmitted infections264 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2010Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress201 cited
  • 2011Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations198 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2007Current Risks of Transfusion-Transmitted Agents: A Review162 cited
  • 2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

154 cited
  • 2009Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa139 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
  • 2013The N ational H eart, L ung, and B lood I nstitute R ecipient E pidemiology and D onor E valuation S tudy ( REDS ‐ III ): a research program striving to improve blood donor and transfusion recipient outcomes109 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2007Current risk for transfusion transmitted infections104 cited
  • 2008Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey99 cited